[S-20] シンポジウム20 Cutting-edge advances in NMOSD and MOG-related disorders

[S-20-3] アクアポリン4抗体陽性視神経脊髄炎スペクトラム障害の治療

^○藤原 一男^1,2 (1.福島県立医科大学多発性硬化症治療学, 2.脳神経疾患研究所 多発性硬化症・視神経脊髄炎センター)

Kazuo Fujihara, M.D.is Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, and Director, Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama, Japan. He is currently serving as President (2018~) of Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), and President (2019~) of Japanese Society for Neuroimmunology (JSNI).